| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, COO &Managing Director E | EVP &Chief Operating Officer | EVP COO &Managing Dir Eur/ Int
1 company
Tovey Christopher J. serves as an EVP, COO &Managing Director E at JAZZ. Across recent SEC filings that breaks down to 0 buys and 2 sells. Those positions are worth an estimated $397 at current prices.
The biggest single holding is JAZZ (~$397) as EVP, COO &Managing Director E. The recent filings there lean toward selling, a net 5,209 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2022 | JAZZ Jazz Pharmaceuticals Plc | EVP, COO &Managing Director E | Sale+OE | 5,209 | $160.00 | $833,440.00 | -26.2% | -15.4% | -22.7% |